An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment.

An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment.

Show other versions (1)
Bibliographic Details
Main Authors: Gelderblom, H, Perol, D, Chevreau, C, Tattersall, M, Stacchiotti, S, Casali, P, Cropet, C, Piperno-Neumann, S, Le Cesne, A, Italiano, A, Ferraresi, V, Duffaud, F, Penel, N, Dileo, P, Bertucci, F, Hassan, A, Kroep, JR, Denizot-Guillemaut, S, Blay, J
Format: Journal article
Published: 2013
Description
Summary:

Similar Items